The biological differences between ovarian serous carcinoma and diffuse peritoneal malignant mesothelioma

October 17, 2006 | Comments Off on The biological differences between ovarian serous carcinoma and diffuse peritoneal malignant mesothelioma

Seminars in Diagnostic Pathology. 2006 Feb;23(1):35-43. [Link] Davidson B, Risberg B, Berner A, Bedrossian CW, Reich R. Department of Pathology, Norwegian Radium Hospital-National Hospital, University of Oslo, Oslo, Norway. ben.davidson@radiumhospitalet.no…

Spindle cell tumors of the pleura: differential diagnosis

October 17, 2006 | Comments Off on Spindle cell tumors of the pleura: differential diagnosis

Seminars in Diagnostic Pathology. 2006 Feb;23(1):44-55. [Link] Rdzanek M, Fresco R, Pass HI, Carbone M. Thoracic Oncology Program, Cardinal Bernardin Cancer Center, Loyola University, Maywood, Illinois, USA. Abstract Spindle cell…

The pathogenesis of mesothelioma

October 17, 2006 | Comments Off on The pathogenesis of mesothelioma

Seminars in Diagnostic Pathology. 2006 Feb;23(1):56-60. [Link] Carbone M, Bedrossian CW. Thoracic Oncology Program, Cancer Research Center of Hawaii, University of Hawaii, Honolulu, Hawaii 96813, USA. mcarbone@crch.hawaii.edu Abstract Widespread asbestos…

Molecular tumor markers for asbestos-related mesothelioma: Serum diagnostic markers

October 17, 2006 | Comments Off on Molecular tumor markers for asbestos-related mesothelioma: Serum diagnostic markers

Pathology International. 2006 Nov;56(11):649-54. [Link] Maeda M, Hino O. Immuno-Biological Laboratories, Fujioka, Gunma, Japan. Abstract Mesothelioma is an aggressive tumor arising from the mesothelium, and is usually associated with previous…

The effect of a novel transition state inhibitor of methylthioadenosine phosphorylase on pemetrexed activity

October 17, 2006 | Comments Off on The effect of a novel transition state inhibitor of methylthioadenosine phosphorylase on pemetrexed activity

Molecular Cancer Therapy. 2006 Oct;5(10):2549-55. [Link] Chattopadhyay S, Zhao R, Tsai E, Schramm VL, Goldman ID. Department of Medicine and Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, New York…

Silencing the receptor EphA2 suppresses the growth and haptotaxis of malignant mesothelioma cells

October 17, 2006 | Comments Off on Silencing the receptor EphA2 suppresses the growth and haptotaxis of malignant mesothelioma cells

Cancer. 2006 Oct 13; [Epub ahead of print] [Link] Najmunnisa Nasreen, PhD, Kamal A. Mohammed, PhD, Veena B. Antony, MD * Division of Pulmonary and Critical Care Medicine, Department of…

Unique Uptake of Acid-Prepared Mesoporous Spheres by Lung Epithelial and Mesothelioma Cells

October 14, 2006 | Comments Off on Unique Uptake of Acid-Prepared Mesoporous Spheres by Lung Epithelial and Mesothelioma Cells

American Journal of Respiratory Cell and Molecular Biology. 2006 Oct 12; [Epub ahead of print] [Link] Steven R Blumen1, Kai Cheng2, Maria E Ramos-Nino1, Douglas J Taatjes1, Daniel J Weiss3,…

Epidemiology of peritoneal mesothelioma: a review

October 13, 2006 | Comments Off on Epidemiology of peritoneal mesothelioma: a review

Annals of Oncology. 2006 Oct 9; [Epub ahead of print] [Link] P. Boffetta 1 * 1 International Agency for Research on Cancer, Lyon, France * To whom correspondence should be…

Morbidity and Mortality Assessment of Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Diffuse Malignant Peritoneal Mesothelioma—A Prospective Study of 70 Consecutive Cases

October 13, 2006 | Comments Off on Morbidity and Mortality Assessment of Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Diffuse Malignant Peritoneal Mesothelioma—A Prospective Study of 70 Consecutive Cases

Annals of Surgical Oncology. 2006 Oct 10; [Epub ahead of print] [Link] Yan TD, Edwards G, Alderman R, Marquardt CE, Sugarbaker PH. Peritoneal Surface Malignancy Program, Washington Cancer Institute, Washington…

5-year prospective results of trimodality treatment for malignant pleural mesothelioma

October 13, 2006 | Comments Off on 5-year prospective results of trimodality treatment for malignant pleural mesothelioma

The Journal of Cardiovascular Surgery (Torino). 2006 Oct;47(5):595-601. [Link] Pagan V, Ceron L, Paccagnella A, Pizzi G. Division of Thoracic Surgery, Umberto I General Hospital, Venezia-Mestre, Italy. Abstract Aim: Even…

Categories